IFNG and cancer: To date, IFN-γ-driven immune evasion and ICBT resistance mechanisms are mainly explained by (1) the induction of immunosuppressive molecules, (2) the up-regulation of negative-feedback regulators, (3) epigenetic effects of chronic exposure, and (4) driving dedifferentation of cancer cells or otherwise affecting antigen processing (Figure 2).